Nymox Pharmaceutical Corp (NYMX)

Occasionally, while trying to net some points on CAPs, I let the 20 minute wait rule on CAPs get me rattled. I open and close my down thrumbs several times trying to time a peak. Several times now, in my haste, I've let the stock pick activate after opening and cancelling it a few times, and not changing the pick to down on the last cycle, leaving me in the WRONG direction. Most pharaceuticals, in early trials will get some positive news that drives the speculators, looking for a Dendron or HGSI type gain. Typically the buy on the news is overdone and profit takers get a few cycles. These are often promising companies, but from the CAPs perspective of "short run" they aren't likely to pan out until the FDA gets it's day. I do like Nymox's chances, and I have friends suffering from Liver Cancer. In the long run, I might be a buyer, possibley even at todays $4.75 price. The $7.07 this spiked to, just a few days ago when I attempted to swing trade it on caps and wrong way'd it, was clearly a market "over" reaction. Like my green thumb, those buying at $7.07 will come out ahead, if they hold, and Nymox progresses further into the FDA cycle. If proven safe and effective, then those willing to incur the risk by getting in early stand the most to gain. Best of luck to Nymox long holders. I expect to turn this pick green in the future, but lower starting price would have been nicer! Swing trading is best done by those with more time to "play" and better attention spans, (real time opening and closing bids would help)!

Nymox seems to believe that if they don't mention cash in their PR, and they don't release earnings statements or balance sheets, then somehow it won't matter that they apparently have no cash. They've just initiated dosing in one large phase III trial with a second on the way, and they have no partner. Their burn will explode and the only way they will be able to keep going is with massive dilution. Their rise back above 120M is a complete and utter mystery. Some very naive investors are going to get splattered.